|Bid||25.13 x 800|
|Ask||25.14 x 1400|
|Day's range||24.92 - 25.26|
|52-week range||23.07 - 57.65|
|Beta (5Y monthly)||0.84|
|PE ratio (TTM)||6.83|
|Forward dividend & yield||0.96 (3.88%)|
|Ex-dividend date||12 May 2022|
|1y target est||N/A|
Philips' (PHG) launches innovative new solutions to attract customers amid a global supply crunch and drive top-line growth.
Koninklijke Philips' (PHG) Q1 top- and bottom-line results reflect negative impact of supply chain constraints and consequences of the Respironics field action.
Philips (PHG) launches two major cardiological innovations at ACC 2022, adding strength and depth to its existing healthcare portfolio.